GRFS
Price:
$7.82
Market Cap:
$5.73B
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic ...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2011-06-02
Stock Exchange
NASDAQ
Ticker
GRFS
Dividends are a key part of long-term returns for investors, and Grifols, S.A. (GRFS) has a track record worth reviewing. Looking at dividend history for GRFS gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2021-06-03
Dividend Yield
0%
Annual Dividend
$0.44
P/E Ratio
31.28
Payout Ratio
0
Dividend per Share
$0
EPS
0.25
Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
---|---|---|---|---|
2021-06-03 | $0.4385 | $0.456 | 2021-06-14 | 2021-05-26 |
2020-10-30 | $0.201 | $0.201 | 2020-11-09 | 2020-10-22 |
2019-12-02 | $0.22 | $0.22 | 2019-12-11 | 2019-10-31 |
2019-06-07 | $0.174 | $0.174 | 2019-06-18 | 2019-05-29 |
2018-11-30 | $0.228 | $0.2283 | 2018-12-11 | 2018-11-07 |
2018-06-01 | $0.251 | $0.251 | 2018-06-12 | 2018-05-25 |
2017-12-01 | $0.212 | $0.212 | 2017-12-12 | |
2017-05-30 | $0.163 | $0.163 | 2017-06-08 | 2017-05-26 |
2016-12-05 | $0.191 | $0.191 | 2016-12-14 | 2016-11-22 |
2016-06-02 | $0.159 | $0.159 | 2016-06-15 | 2016-05-31 |
2015-12-10 | $0.37 | $0.185 | 2015-12-17 | 2015-12-01 |
The table below shows Grifols, S.A. (GRFS) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Grifols, S.A. (GRFS) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
Stock name | Dividend yield |
---|---|
Novartis AG (NVS) | 0.04% |
AstraZeneca PLC (AZN) | 0.01% |
GSK plc (GSK) | 0.05% |
Roche Holding AG (RHHBY) | 0.04% |
Bristol-Myers Squibb Company (BMY) | 0.04% |
Merck & Co., Inc. (MRK) | 0.03% |
Gilead Sciences, Inc. (GILD) | 0.03% |
Amgen Inc. (AMGN) | 0.03% |
Sanofi (SNY) | 0.04% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Grifols, S.A. (GRFS) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is GRFS’s dividend yield?
What is the difference between regular and special dividends?
Has GRFS increased its dividends over time?
Why might dividend history data be delayed?
How often does GRFS pay dividends?
What factors impact GRFS's dividend payments?
Can dividends change over time?
What is GRFS’s next dividend date?